2 hours BTIG Research Reaffirms Buy Rating for Humacyte (NASDAQ:HUMA)MarketBeat
BTIG Research restated a “buy” rating and set a $10.00 price target on shares of Humacyte in a report on Friday.
XBTIG Research restated a “buy” rating and set a $10.00 price target on shares of Humacyte in a report on Friday.
X